000119312515100228txt 20150320 000119312515100228hdrsgml 20150320 20150320162936 accession number 000119312515100228 conformed submission type sc 14d9a public document count 2 filed date 20150320 date change 20150320 subject company company data company conformed name salix pharmaceutical ltd central index key 0001009356 standard industrial classification pharmaceutical preparation 2834 irs number 943267443 state incorporation de fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00553269 film number 15716584 business address street 1 8510 colonnade center drive city raleigh state nc zip 27615 business phone 919 8621000 mail address street 1 8510 colonnade center drive city raleigh state nc zip 27615 former company former conformed name salix holding ltd date name change 19970807 filed by company data company conformed name salix pharmaceutical ltd central index key 0001009356 standard industrial classification pharmaceutical preparation 2834 irs number 943267443 state incorporation de fiscal year end 1231 filing value form type sc 14d9a business address street 1 8510 colonnade center drive city raleigh state nc zip 27615 business phone 919 8621000 mail address street 1 8510 colonnade center drive city raleigh state nc zip 27615 former company former conformed name salix holding ltd date name change 19970807 sc 14d9a 1 d893076dsc14d9ahtm amendment no 5 schedule 14d9 amendment no 5 schedule 14d9 united state security exchange commission washington dc 20549 schedule 14d9 amendment no 5 solicitationrecommendation statement section 14d4 security exchange act 1934 salix pharmaceutical ltd name subject company salix pharmaceutical ltd name person filing statement common stock par value 0001 per share title class security 795435106 cusip number class security william bertrand jr acting chief operating officer executive vice president general counsel salix pharmaceutical ltd 8510 colonnade center drive raleigh north carolina 27615 919 8621000 copy to christopher t cox gregory p patti jr cadwalader wickersham taft llp one world financial center new york ny 10281 212 5046000 name address telephone number person authorized receive notice communication behalf person filing statement ¨ check box filing relates solely preliminary communication made commencement tender offer purpose amendment amendment no 5 this “amendment no 5” amends supplement solicitationrecommendation statement schedule 14d9 salix pharmaceutical ltd the “company” “we” filed security exchange commission the “sec” march 6 2015 a heretofore amended supplemented time time “schedule 14d9” schedule 14d9 relates tender offer sun merger sub inc delaware corporation “purchaser” wholly owned subsidiary valeant pharmaceutical international delaware corporation “vpi” wholly owned subsidiary valeant pharmaceutical international inc british columbia corporation “valeant” acquire outstanding share common stock par value 0001 per share the “shares” company 17300 per share net seller cash without interest le required withholding tax the “offer price” offer price subject reduction 15800 per share condition offer a defined below satisfied waived purchaser 1200 midnight eastern time april 8 2015 one minute 1159 pm eastern time april 7 2015 upon term subject condition set forth i offer purchase dated march 4 2015 a amended supplemented time time including amendment supplement offer purchase dated march 17 2015 “offer purchase” ii related letter transmittal accompanied offer purchase which together amendment supplement thereto collectively constitute “offer” offer described tender offer statement schedule a amended supplemented time time filed valeant vpi purchaser sec march 4 2015 except otherwise set forth below information set forth schedule 14d9 remains unchanged incorporated reference relevant item amendment no 5 capitalized term used defined herein shall meaning assigned term schedule 14d9 amendment no 5 filed reflect certain update set forth below item 9 exhibit item 9 schedule 14d9 hereby amended supplemented adding following exhibit exhibit description document a26 valeant acquisition question answer document signature due inquiry best knowledge belief certify information set forth schedule 14d9 true complete correct salix pharmaceutical ltd by s william bertrand jr dated march 20 2015 name william c bertrand jr title acting chief operating officer executive vice president general counsel ex99a26 2 d893076dex99a26htm ex99a26 ex99a26 exhibit a26 valeant acquisition question answer document salix employee following question answer use leader manager employee salix message used guide – creating consistent reference point communication related announcement close acquisition valeant integration activity purpose purpose internal question answer document consistent reference point question related acquisition valeant 1 exhibit a26 1 still expand field sale force preparation ibsd approval valeant management reviewing part overall integration planning process expect information provided transaction close 2 asked stay part transition team say 3 month valeant transaction close told retained end 3month transition period decline offer stay transition employee still eligible severance no stay designated last day considered voluntarily resigned eligible severance 3 asked stay period time transition earn pto so salix pto accrual rate valeant vacation accrual rate continue accrue pto long active employee including transition time accrue salix rate transition valeant benefit occurs expect within sixty day transaction closing 4 retained terminated employees’ 401k impacted also company match yet vested taken back salixvaleant vest entirety transaction close valeant anticipates salix 401k plan merge valeant 401k plan transaction close happens contribution continue vest 25 per year long employed 5 receive severance payment include deduction eg 401k life insurance etc deduction required withholding taken severance pay 6 severance payment begin retained short period time severance payment begin termination date signed separation agreement applicable revocation period expired also important note termination date must within 12 month date transaction close severance pay benefit employee retention policy apply 7 field employee eligible promotion example sale rep territory manager likely appreciate many different thing reviewed part integration planning process question one them expect information provided transaction close 8 employee retained transaction close severance paid installment lump sum valeant currently reviewing matter provide information shortly 2 exhibit a26 9 find salix employee retention policy policy may found salix intranet “resourceshandbooks policies” httpsportalsalixcomresourcesdocumentspoliciesemployee20retention20policypdf 10 offered job salary slightly different title responsibility transaction close don’t accept still qualify severance would qualify severance change meet term contained salix employee retention policy 11 draw unemployment getting severance salix valeant control eligibility receive unemployment state different eligibility law please contact local unemployment employment security office 12 salixvaleant withhold tax severance payment salary bonus yes required law withhold applicable tax 13 retained valeant severance package employee retention policy include health insurance benefit please see employee retention policy state receive paid continuation benefit period time severance pay calculated 14 salix 401k company match stop transaction close salix 401k plan remain place transitioned valeant’s 401k plan expect occur within 60 day deal close 15 retained salix pto balance carried valeant valeant planning transition salix employee valeant payroll benefit within 60 day transaction closing receive additional information regarding pto well benefit transition process begin shortly closing 16 anniversary related pto increase valeant honor these retained salix tenure honored purpose determining benefit servicebased compensation benefit program extent allowed law andor applicable benefit plan compensation program 17 currently enrolled fsa andor dependent care long file reimbursement plan go away would grace period apply fsa end last day employment 45 day submit claim service provided january 1 2015 last day dependent care fsa continued cobra health care fsa may continued cobra described below if last day spent money health care fsa contributed offered health care fsa cobra example elected annual amount 1200 300 ytd payroll deduction filed claim 400 service offered health care fsa cobra additionally pay company back excess spend day since eligible use entire 1200 first day coverage rule governed irs 3 exhibit a26 if last day spent money health care fsa contributed offered health care fsa cobra example elected annual amount 1200 300 ytd payroll deduction filed claim 200 service offered health care fsa cobra important note fsa cobra coverage pretax paid entirely you additionally elect health care fsa cobra excess fund left account amount refunded revert company rule governed irs 18 happen 529 collegeboundfund alliancebernstein transaction close payroll deduction end transition valeant’s benefit plan leave company whichever earlier 529 account individual account able manage fund outside payroll deduction continue deduction call alliancebernstein 8883245057 get information 19 signed legal shield year happen account retained transaction close able continue coverage legal shield bank draft option valeant also legal plan active employee able enroll in 20 happens life insurance benefit severed life insurance end last day employment opportunity convert salix life insurance policy personal policy 21 valeant severance policy yes valeant severance policy provides two week severance per completed year service maximum 26 week severance 22 tax implication unvestedvested share tax taken payment stock vesting connection transaction 25 federal income tax withholding 1m supplemental wage 396 federal income tax withholding supplemental wage exceeding 1m this amount 1m 62 social security withholding up max 118500 145 medicare withholding state income tax withholding different percentage state supplemental wage bonus stock severance pto specific question related tax implication stock payouts encourage consult financial advisor 23 receive check stock vest result closing transaction receive payment stock held solium vest result closing within 3 business day transaction close 4 exhibit a26 24 paid stock directly deposited account file payroll receive live pay check receive live check stock payout 25 salixvaleant withhold tax stock payouts yes applicable tax withheld 26 still paid q1 salix performance current ic structure field employee yes still paid earned field bonus q1 based current ic plan 27 q2 bonus prorated retained midway q2 bonus paid expect paid atabout time q2 ic payment made 28 event tm retained received severance package long would able use company car returned severance contingent upon completing closeout activity including return company vehicle contacted directly regarding return vehicle must timely fashion 29 tell customer ask acquisition customer ask acquisition please tell transaction close “business usual” salix valeant continue sell market product customer acquisition finalized 30 tell contractorsconsultants contractorsconsultants continue time decision made longer needed 31 deliver annual review fieldbased employee please plan deliver facetoface annual review april 1528 working possible contingent plan anything need changed pending confirmed closing date important information investor security holder communication constitute offer buy solicitation offer sell security tender offer statement schedule to including offer purchase letter transmittal related document filed security exchange commission the “sec” subsidiary valeant pharmaceutical international solicitationrecommendation statement schedule 14d9 filed sec salix pharmaceutical ltd “salix” tender offer made pursuant offer purchase letter transmittal related document filed part schedule to investor stockholder salix urged read tender offer statement solicitationrecommendation statement regarding tender offer amendment supplement thereto document filed sec become available contain or contain important information material sent free charge salix stockholder may also obtained salix’s website wwwsalixcom addition material and tender offer document filed sec available charge sec website wwwsecgov 5